摘要 |
The peptide VIRIP (human virus-inhibiting peptide) and its biologically active fragments and/or variants and/or derivatives, especially amidated, acetylated, sulfated, poly(ethylene glycol)-modified, phosphorylated and/or glycosylated derivatives, also synthetic peptides with the same biological activity (collectively (I)). VIRIP has the formula (1) Z1-LEAIPMSIPPEVKFNKPF-Z2 (1) Z1 and Z2 : 0-10 amino acids, or Z1 = hydrogen and Z2 = carboxy Independent claims are also included for the following: (a) nucleic acid (II) encoding (I); (b) vector containing (II); (c) genetically modified host cell containing the vector; (d) nucleic acid (IIa) that hybridizes with (II); (e) antibody (Ab), antagonist or inhibitor of (I); (f) combination of (I) and an adapter protein that ensures uptake into virus-infected cells; (g) galenical formulation containing (I) and a carrier; (h) method for preparing (I); (i) diagnostic agent containing Ab or (II); and (j) pharmaceutical composition containing (I), (II), Ab or an antagonist/inhibitor of (I). - ACTIVITY : Antiviral; antibacterial; antifungal; anti-inflammatory; anticancer; growth regulating; neurological; cardiovascular; hematological; immunomodulatory; vulnerary. In peripheral blood mononuclear cells, incubation with 1000 Microg/ml VIRIP caused almost complete inhibition of replication (assessed from reverse transcriptase activity) of many different strains of human immune deficiency virus, regardless of the tropism of the virus. - MECHANISM OF ACTION : Viral receptor blocker. |